Login to Your Account

Bharat Biotech wins WHO prequalification for typhoid vaccine

By T.V. Padma
Staff Writer

Wednesday, January 10, 2018

NEW DELHI – The World Health Organization (WHO) has pre-qualified Indian company Bharat Biotech International Ltd.'s Typbar TCV, its conjugate vaccine against typhoid fever. The pre-qualification paves the way for possible use in childhood immunization programs against typhoid in high-risk, endemic countries.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription